Corbus Pharmaceuticals Q4 EPS $(1.25) Beats $(1.38) Estimate
Corbus Pharmaceuticals (NASDAQ:CRBP) reported quarterly losses of $(1.25) per share which beat the analyst consensus estimate of $(1.38) by 9.42 percent. This is a 60.26 percent decrease over losses of $(0.78) per share
